The emerging era of genomic data integration for analyzing splice isoform function

Trends in Genetics

Volumn 30, Issue 8, 2014, Pages 340-347

  Li, Hong Dong ^a   Menon, Rajasree ^a   Omenn, Gilbert S ^a   Guan, Yuanfang ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancers; Development; Function prediction; Genomic data integration; Splice isoforms

Indexed keywords

RNA ISOFORM; TRANSCRIPTOME; ISOPROTEIN; PROTEIN;

ALTERNATIVE RNA SPLICING; FUNCTIONAL GENOMICS; GENE FUNCTION; GENOMICS; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE; ANIMAL; BIOLOGY; GENETICS;

ALTERNATIVE SPLICING; ANIMALS; COMPUTATIONAL BIOLOGY; GENOMICS; HUMANS; PROTEIN ISOFORMS; PROTEINS;

EID: 84904756759     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2014.05.005     Document Type: Review

References (96)

1. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2007, 72:291-336.
2. Barash Y., et al. Deciphering the splicing code. Nature 2010, 465:53-59.
3. Ferreira E., et al. Alternative splicing enriched cDNA libraries identify breast cancer-associated transcripts. BMC Genomics 2010, 11:S4.
4. Modrek B., et al. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acid Res. 2001, 29:2850-2859.
5. Griffith M., et al. Alternative expression analysis by RNA sequencing. Nat. Methods 2010, 7:843-847.
6. Light S., Elofsson A. The impact of splicing on protein domain architecture. Curr. Opin. Struct. Biol. 2013, 23:451-458.
7. Ellis, Jonathan D., et al. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol. Cell 2012, 46:884-892.
8. Lewis B.P., et al. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:189-192.
9. Sanford J.R., et al. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 2004, 18:755-768.
10. Pan Q., et al. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40:1413-1415.
11. Harrow J., et al. GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 2012, 22:1760-1774.
12. Consortium E.P. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636-640.
13. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
14. Stamm S., et al. Function of alternative splicing. Gene 2005, 344:1-20.
15. Tress M.L., et al. The implications of alternative splicing in the ENCODE protein complement. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5495-5500.
16. Eksi R., et al. Systematically differentiating functions for alternatively spliced isoforms through integrating RNA-seq data. PLoS Comput. Biol. 2013, 9:e1003314.
17. Omenn G.S., et al. Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications. Dis. Markers 2010, 28:241-251.
18. Menon R., et al. Functional implications of structural predictions for alternative splice proteins expressed in Her2/neu-induced breast cancers. J. Proteome Res. 2011, 10:5503-5511.
19. Menon R., et al. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. Cancer Res. 2009, 69:300-309.
20. Omenn G.S., et al. Innovations in proteomic profiling of cancers: alternative splice variants as a new class of cancer biomarker candidates and bridging of proteomics with structural biology. J. Proteomics 2013, 90:28-37.
21. Revil T., et al. Protein kinase C-dependent control of Bcl-x alternative splicing. Mol. Cell. Biol. 2007, 27:8431-8441.
22. Skalka N., et al. Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway. Oncogene 2013, 32:2836-2847.
23. Zheng S., Black D.L. Alternative pre-mRNA splicing in neurons: growing up and extending its reach. Trends Genet. 2013, 29:442-448.
24. Yano M., et al. Nova2 regulates neuronal migration through an RNA Switch in disabled-1 signaling. Neuron 2010, 66:848-858.
25. Ule J., et al. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 2005, 37:844-852.
26. Li Q., et al. Neuronal regulation of alternative pre-mRNA splicing. Nat. Rev. Neurosci. 2007, 8:819-831.
27. Gabut M., et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147:132-146.
28. Baumann K. Stem cells: tailored splicing patterns. Nat. Rev. Mol. Cell Biol. 2013, 14:464-465.
29. Aaronson Y., Meshorer E. Stem cells: regulation by alternative splicing. Nature 2013, 498:176-177.
30. Han H., et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 2013, 498:241-245.
31. Salomonis N., et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:10514-10519.
32. Suzuki H., et al. Comprehensive analysis of alternative splicing and functionality in neuronal differentiation of P19 Cells. PLoS ONE 2011, 6:e16880.
33. Revil T., et al. Alternative splicing is frequent during early embryonic development in mouse. BMC Genomics 2010, 11:399.
34. Boutz P.L., et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 2007, 21:1636-1652.
35. Srebrow A., Kornblihtt A.R. The connection between splicing and cancer. J. Cell Sci. 2006, 119:2635-2641.
36. Wang G-S., Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 2007, 8:749-761.
37. Menon R., Omenn G.S. Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers. Cancer Res. 2010, 70:3440-3449.
38. Fackenthal J., Godley L.A. Aberrant RNA splicing and its functional consequences in cancer cells. Dis. Model Mech. 2008, 1:1754-8411.
39. Bourdon J-C., et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 2005, 19:2122-2137.
40. Tammaro C., et al. BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer. Biochem. Soc. Trans. 2012, 40:768-772.
41. Scotlandi K., et al. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene 2007, 26:6604-6618.
42. Veggran F., et al. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Clin. Cancer Res. 2006, 12:5794-5800.
43. Liu Z., et al. Nek2C functions as a tumor promoter in human breast tumorigenesis. Int. J. Mol. Med. 2012, 30:775-782.
44. Ashburner M., et al. Gene ontology: tool for the unification of biology. Nat. Genet. 2000, 25:25-29.
45. Kanehisa M., et al. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32:D277-D280.
46. Subramanian A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15545-15550.
47. Troyanskaya O.G., et al. A Bayesian framework for combining heterogeneous data source for gene function prediction (in Saccharomyces cerevisiae). Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8348-8353.
48. Guan Y., et al. Predicting gene function in a hierarchical context with an ensemble of classifiers. Genome Biol. 2008, 9(Suppl. 1):S3.
49. Schietgat L., et al. Predicting gene function using hierarchical multi-label decision tree ensembles. BMC Bioinformatics 2010, 11:2.
50. Guan Y., et al. A genomewide functional network for the laboratory mouse. PLoS Comput. Biol. 2008, 4:e1000165.
51. Franke L., et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am. J. Hum. Genet. 2006, 78:1011-1025.
52. Lee I., et al. A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans. Nat. Genet. 2008, 40:181-188.
53. Lee I., et al. An improved, bias-reduced probabilistic functional gene network of baker's yeast, Saccharomyces cerevisiae. PLoS ONE 2007, 2:e988.
54. Guan Y., et al. Tissue-specific functional networks for prioritizing phenotypes and disease genes. PLoS Comput. Biol. 2012, 8:e1002694.
55. Guan Y., et al. Functional genomics complements quantitative genetics in identifying disease-gene associations. PLoS Comput. Biol. 2010, 6:e1000991.
56. Stelzl U. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122:957-968.
57. Schwikowski B., et al. A network of protein-protein interactions in yeast. Nat. Biotechnol. 2000, 18:1257-1261.
58. Franceschini A., et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, 41:D808-D815.
59. Licata L., et al. MINT, the molecular interaction database: 2012 update. Nucleic Acids Res. 2012, 40:D857-D861.
60. Giot L., et al. A protein interaction map of Drosophila melanogaster. Science 2003, 302:1727-1736.
61. Dey B., et al. DNA-protein interactions: methods for detection and analysis. Mol. Cell. Biochem. 2012, 365:279-299.
62. Carey M.F., et al. Confirming the functional importance of a protein-DNA interaction. Cold Spring Harb. Protoc. 2012, 7:733-757.
63. Wang X., et al. Network-based methods for human disease gene prediction. Brief. Funct. Genomics 2011, 10:280-293.
64. Wu X., et al. Network-based global inference of human disease genes. Mol. Syst. Biol. 2008, 4:189.
65. Moreau Y., Tranchevent L-C. Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat. Rev. Genet. 2012, 13:523-536.
66. Menon R., Omenn G.S. Identification of alternatively spliced transcripts using a proteomic informatics approach. Methods Mol. Biol. 2011, 696:319-326.
67. Li W., et al. High-resolution functional annotation of human transcriptome: predicting isoform functions by a novel multiple instance-based label propagation method. Nucleic Acids Res. 2013, 1-15.
68. Corominas R., et al. Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism. Nat. Commun. 2014, 5:3650.
69. Rentzsch R., Orengo C.A. Protein function prediction using domain families. BMC Bioinformatics 2013, 14(Suppl. 3):S5.
70. Forslund K., Sonnhammer E.L.L. Predicting protein function from domain content. Bioinformatics 2008, 24:1681-1687.
71. Lee D., et al. Predicting protein function from sequence and structure. Nat. Rev. Mol. Cell Biol. 2007, 8:995-1005.
72. Whisstock J., Lesk A. Prediction of protein function from protein sequence and structure. Q. Rev. Biophys. 2003, 36:307-340.
73. Laskowski R.A., et al. ProFunc: a server for predicting protein function from 3D structure. Nucleic Acids Res. 2005, 33:W89-W93.
74. Roy A., et al. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5:725-738.
75. Konc J., et al. Structure-Based Function Prediction of Uncharacterized Protein Using Binding Sites Comparison. PLoS Comput. Biol. 2013, 9:e1003341.
76. Berman H.M., et al. The Protein Data Bank. Nucleic Acids Res. 2000, 28:235-242.
77. Trapnell C., et al. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25:1105-1111.
78. Langmead B., et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
79. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
80. Trapnell C., et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
81. Roberts A., Pachter L. Streaming fragment assignment for real-time analysis of sequencing experiments. Nat. Methods 2013, 10:71-73.
82. Andrews S., et al. Multiple instance learning with generalized support vector machines. AAAI-02 Proceedings 2002, 943-944.
83. Alam F.I., Gondra I. A Bayesian network-based tunable image segmentation algorithm for object recognition. 2011 IEEE International Symposium on Signal Processing and Information Technology (ISSPIT) 2011, 11-16.
84. Wang J., Zucker J-D. Solving the multiple-instance problem: a lazy learning approach. Proc. 17th Intl. Conf. on Machine Learning 2000, 1119-1125.
85. Kamijo T., et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8292-8297.
86. Dunham I., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
87. Omenn G.S., et al. A new class of protein cancer biomarker candidates: Differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines. J. Proteomics 2014, 10.1016/j.jprot.2014.04.012.
88. Du K.L., et al. Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells. J. Biol. Chem. 2004, 279:17578-17586.
89. Xu Z., et al. The MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosis. Mol. Cell. Biol. 2001, 21:4713-4724.
90. Bjorkholm M., et al. Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1. Blood 2013, 121:4807.
91. Scharenberg M.A., et al. TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J. Cell Sci. 2014, 141:e707.
92. Franco S.J., et al. Reelin regulates cadherin function via Dab1/Rap1 to control neuronal migration and lamination in the neocortex. Neuron 2011, 69:482-497.
93. Gao Z., et al. Splice-mediated motif switching regulates disabled-1 phosphorylation and SH2 domain Interactions. Mol. Cell. Biol. 2012, 32:2794-2808.
94. Nicholson R.I., et al. EGFR and cancer prognosis. Eur. J. Cancer 2001, 37:9-15.
95. Baron A.T., et al. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 2003, 12:103-113.
96. Wilken J.A., et al. The epidermal growth factor receptor conundrum. Cancer 2010, 117:2358-2360.